Through the analysis of 65 high-grade serous ovarian cancers, our study showed significant enrichment of both the expression of BTN3A1 and the accumulation of γδ T cells in human ovarian cancer compared to tumor-free ovaries or the fallopian tube [3]. This evidence concerns the gene BTN3A1 and ovarian carcinoma.